Goran Augustin | Abdominal infections | Best Researcher Award

Published on by Infectious

Dr. Goran Augustin | Abdominal infections | Best Researcher Award 

MD, PhD | University Hospital Centre Zagreb | Croatia

Dr. Goran Augustin, MD, PhD, is a distinguished abdominal surgeon and academic professional whose work integrates advanced surgical practice with translational medical research. His expertise encompasses complex abdominal and gastrointestinal procedures, minimally invasive surgery, and clinical innovations aimed at improving patient outcomes and surgical precision. Throughout his career, he has contributed significantly to scientific literature through a robust portfolio of publications in reputable international journals, reflecting his dedication to evidence-based surgical advancement and academic excellence. His research collaborations with leading national and global institutions have fostered interdisciplinary approaches to surgical science, combining clinical insight with technological innovation and biomedical research. As an advocate for global health and surgical education, Dr. Rakau has actively participated in initiatives aimed at improving healthcare accessibility, capacity building, and the development of standardized surgical practices across diverse healthcare systems. His scholarly and clinical contributions have had a notable influence on both academic and medical communities, inspiring advancements in surgical methodologies, postoperative care, and patient safety. Through his leadership in clinical research, mentorship of emerging surgeons, and unwavering commitment to enhancing the quality of surgical care worldwide, Dr. Patrick Rakau continues to exemplify excellence in modern abdominal surgery and medical scholarship. He has 6061 citations from 179 documents with an h-index of 36.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Age Is Not So Important for Risk Stratification in Early Cholecystectomy for Acute Calculous Cholecystitis: A Post-Hoc Analysis of the SPRiMACC Study Database. (2025). Medicina (Lithuania).

2. Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: An international study. (2025). Intensive Care Medicine.

3. Protective ileostomy creation after anterior resection of the rectum (PICARR): A decision-making exploring international survey. (2025). Updates in Surgery.

4. A Survey on the Management of Patients with Severe Traumatic Brain Injury During Pregnancy: The MAMA Study. (2025). Neurocritical Care.

5. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. (2025). World Journal of Experimental Medicine.

Arslan Amin | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Dr. Arslan Amin | Infectious Diseases Prevention | Best Researcher Award

Arslan Amin | Huazhong University of Science and Technology | China

Arslan Amin is a distinguished researcher and communication professional with expertise in media studies, digital communication, health communication, and political communication. His research focuses on the intersections of media, technology, and societal well-being, with a particular emphasis on the impact of social media, media bias, and digital innovations on public perception and behavior. He has published extensively in internationally recognized journals, contributing to critical discourse on AI-driven mental health interventions, racial discrimination and healthcare access, and the influence of deepfake media on political ideology and polarization. His work demonstrates a strong commitment to evidence-based analysis and the application of communication theory to contemporary societal challenges. Beyond publications, Arslan has led and contributed to numerous media projects, including documentaries, news reporting, educational programming, and public awareness campaigns, reflecting his ability to translate research into practical outcomes. He has presented his findings at international academic conferences, engaging with global scholarly communities to advance knowledge in journalism, media studies, and health communication. Arslan’s contributions have been recognized through editorial responsibilities, professional certifications, and leadership roles in collaborative research initiatives, underscoring his dedication to fostering innovation, interdisciplinary collaboration, and ethical communication practices. With expertise in research methodology, media analysis, and digital communication strategies, he continues to shape the field of communication studies while addressing critical societal issues through rigorous, impactful research.

Profiles : Scopus | Google Scholar

Featured Publications

Amin, A., Hong, Y., & Mazhar, B. (2025). The influence of social media deepfake images on political ideology and polarization: The mediating roles of cognitive load and confirmation bias. Journal of Visual Literacy, 44(3), 321–339.

Amin, A., Amin, S., & Ali, S. (2021). GEO News coverage is more biased than ARY News coverage regarding Panama leaks by viewers’ perception. Media and Communication Review, 1(2), 1–18.

Amin, A., Mazhar, B., & Amin, S. (2025). Mental health effects of online gaming: A mediation–moderation model of connectedness and screen time. Mental Health and Digital Technologies.

Amin, A., Hong, Y., & Mazhar, B. (2025). Enhancing AI-driven mental health solutions: The role of social support in Wysa’s effectiveness for stress management and anxiety reduction among international medical students. International Journal of Human–Computer Interaction, 1–16.

Amin, A. (2025). Racial discrimination and its effects on hypertension and healthcare access among African Americans: A critical race theory approach. Journal of African American Studies, 29(2), 253–271.

Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Published on by Infectious

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Published on by Infectious

Prof. Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Professor | Badji-Mokhtar University | Algeria

Prof. Amel Bouzabata is a distinguished researcher and academic at Université Badji Mokhtar – Annaba, Algeria, recognized for her expertise in analytical chemistry, phytochemistry, and antioxidant studies. She obtained her Ph.D. in Analytical Chemistry from the same university in 2014, where she developed an early interest in the metabolic profiling of natural compounds and the bioactive evaluation of medicinal plants. Over the years, Prof. Bouzabata has built a strong academic and research portfolio focused on natural product analysis, chromatographic techniques, and high-resolution mass spectrometry (HR-LC-ESI-Orbitrap-MS). Her professional experience includes teaching undergraduate and postgraduate chemistry courses, supervising graduate theses, and participating in interdisciplinary research projects that link chemistry with pharmacology and environmental science. She has collaborated with international researchers to explore the biochemical diversity of regional flora, contributing to several peer-reviewed publications in Scopus-indexed and Q1 journals such as Antioxidants and Journal of Natural Products. Her research interests extend to metabolomics, chemometric analysis, and the discovery of novel antioxidant and antimicrobial compounds from natural sources. Prof. Bouzabata’s research skills include advanced chromatographic separation, spectral interpretation, multivariate data analysis, and the use of bioassay-guided fractionation for compound identification. She has received institutional recognition for her scientific contributions and is actively involved in promoting research capacity development among young scientists in Algeria. Through mentorship and collaboration, she has strengthened the university’s research visibility and global academic partnerships. Prof. Bouzabata continues to pursue innovative approaches to natural compound characterization, integrating analytical precision with biological relevance to address emerging scientific and health challenges. Her dedication to high-quality research and international collaboration underscores her growing influence in chemical and biological sciences. Prof. Amel Bouzabata has achieved 420 total citations across 15 published research documents, demonstrating a consistent scholarly impact with an h-index of 11, based on 376 citing documents in Scopus.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Bouzabata, A., Montoro, P., Gil, K. A., Piacente, S., et al. (2022). HR-LC-ESI-Orbitrap-MS-Based metabolic profiling coupled with chemometrics for the discrimination of different Echinops spinosus organs and evaluation of their antioxidant activity.

2. Bouzabata, A. (2015). Contribution à l’étude d’une plante médicinale et aromatique Myrtus communis L. Faculté de Médecine, Université Badji-Mokhtar, Annaba, Algérie.

3. Bouzabata, A., Bighelli, A., Abed, L., Casanova, J., & Tomi, F. (2014). Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Natural Product Communications, 9(5), 1934578X1400900530.

4. Bouzabata, A., & Yavuz, M. (2019). Médecine traditionnelle et ethnopharmacologie en Algérie: de l’histoire à la modernité. Ethnopharmacologia.

5. Bouzabata, A., & Boukhari, A. (2014). Variation in the traditional knowledge of Curcuma longa L. in North-Eastern Algeria. International Journal of Biological, Veterinary, Agricultural and Food Engineering.

 

Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Researcher | Academic Center for Education, Culture and Research | Iran

Dr. Sanaz Ahmadi Ghezeldasht is a distinguished researcher and molecular biologist at the Molecular Biology Section, Central Laboratory ACECR, Mashhad, Iran, specializing in medical immunology, molecular virology, and infectious diseases. She holds a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences, an M.Sc. in Animal Physiology from Payam-e-Noor University of Isfahan, and a B.Sc. in Biology from Ferdowsi University of Mashhad. Dr. Ghezeldasht has served as the Supervisor of the Molecular Biology Center at Jahad Daneshgahi Mashhad, contributing to several national and international research projects focused on HTLV-1 pathogenesis, viral immunology, and host-virus interactions. Her prolific research portfolio encompasses numerous peer-reviewed publications in high-impact journals such as Reviews in Medical Virology, Journal of NeuroVirology, and Applied Biochemistry and Biotechnology, highlighting novel insights into viral oncogenesis, molecular diagnostics, and therapeutic development. A dedicated academic leader, she has organized and contributed to multiple scientific congresses and health monitoring initiatives. Dr. Ghezeldasht’s expertise extends to genetic engineering, bioinformatics, PCR technologies, and cell culture, complemented by certifications in English proficiency and advanced computer literacy. She is an active member of the HTLV-I Foundation and the Research Center for HIV/AIDS, HTLV, and Viral Hepatitis at ACECR, reflecting her enduring commitment to advancing molecular medicine and public health. Her scholarly impact is reflected by 409 citations across 26 publications with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publication

1. Shafaei, A., Talebi, K., Zarean, M., Mosavat, A., Khajedaluee, A. R., Afzalaghaee, M., Shamsian, S. A. A., & Ghezeldasht, S. A. (2025). Intestinal parasitic infections, eosinophilia, and Th1/Th2 immune profiles in haemodialysis patients. Parasite Immunology.

2. Rahimzada, M., Nahavandi, M., Saffari, M., Shafaei, A., Mosavat, A., Ghezeldasht, S. A., Ariaee, N., Valizadeh, N., Rahimi, H., Rezaee, S. A., et al. (2023). Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL). Molecular Biology Reports, 50(9).

3. Yousefpoor, N., Mahdavian, M., Pourbagher, Z., Ghezeldasht, S. A., Mosavat, A., Ziaee, M., Bahreini, M., Soleimanpour, S., Sharifmoghadam, M. R., Valizadeh, N., et al. (2023). Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region. Microbial Pathogenesis, 180, 106170.

4. Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 29(4), 567–578.